{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase 1 study of venetoclax\/azacitidine or venetoclax in combination with ziftomenib (KO-539) or standard induction cytarabine\/daunorubicin (7+3) chemotherapy in combination with ziftomenib for the treatment of patients with acute myeloid leukemia","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-1-study-of-venetoclax-azacitidine-or-venetoclax-in-combination-with-ziftomenib-ko-539-or-standard-induction-cytarabine-daunorubicin-73-chemotherapy-in-combination-with-ziftomenib-for-the-tr\/#breadcrumbitem"}]}